S&P 및 Nasdaq 내재가치 문의하기

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lite Strategy, Inc. (LITS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

애널리스트 추정 주당순이익(EPS) $3.62 및 매출 $0.07B 다음 회계연도.

주당순이익(EPS) 실적 추이: 2024: 실적 $2.67 vs 추정 $3.62 (하회 -26.2%). 2025: 실적 $-2.39 vs 추정 $-6.28 (상회 +61.9%). 애널리스트 정확도: 1%.

EPS 전망 — LITS

1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $2.67 vs Est $3.62 ▼ 35.6% off
2025 Actual –$2.39 vs Est –$6.28 ▲ 162.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

매출 전망 — LITS

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.065B vs Est $0.065B ▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기